Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€3.52
31.10.20
-
04.11.21
40.96%
05.11.20

buy
ElringKlinger AG

Start price
Target price
Perf. (%)
€8.77
31.10.20
-
04.11.21
3.42%
09.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
buy
Canadian Solar Inc.

Start price
Target price
Perf. (%)
€30.91
31.10.20
€39.00
04.11.21
8.35%
14.11.20

Could be very worthwhile Investment >20% year
Top 10 in its market
Small cyclical dependencies
Known brand
Highland Gold Mining

Start price
Target price
Perf. (%)
€3.33
30.10.20
-
04.11.21
-0.42%
14.11.20

Could be worthwhile Investment >10% per year
buy
SRP Groupe S.A.

Start price
Target price
Perf. (%)
€1.18
30.10.20
€3.20
04.11.21
73.43%
05.11.21

Could be worthwhile Investment >10% per year
buy
SMCP

Start price
Target price
Perf. (%)
€3.36
30.10.20
-
04.11.21
137.19%
05.11.21

Could be worthwhile Investment >10% per year
buy
miRagen Therapeutics Inc

Start price
Target price
Perf. (%)
€24.75
30.10.20
€45.00
02.11.20
-39.39%
02.11.20

Risky Investment
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€6.45
29.10.20
-
04.11.21
-0.78%
04.11.20

Could be very worthwhile Investment >20% year
buy
Tricida

Start price
Target price
Perf. (%)
€3.68
29.10.20
€4.00
31.10.20
28.80%
31.10.20

Could be very worthwhile Investment >20% year
buy
ElringKlinger AG

Start price
Target price
Perf. (%)
€8.53
29.10.20
€10.00
31.10.20
2.81%
31.10.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
Cocrystal Pharma Inc.

Start price
Target price
Perf. (%)
€8.64
28.10.20
-
04.11.21
31.94%
15.07.21

Could be very worthwhile Investment >20% year
Kandi Technologies Corp.

Start price
Target price
Perf. (%)
€5.53
28.10.20
€4.70
02.11.20
4.27%
02.11.20

EBIT growth >5% per year expected
Innovative
Future proof or reliable business model
Sustainability is little important
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€267.50
27.10.20
€300.00
31.10.20
8.41%
31.10.20

Could be worthwhile Investment >10% per year
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€9.45
27.10.20
€8.92
31.10.20
-25.93%
31.10.20

Risky Investment
Inovio Pharma

Start price
Target price
Perf. (%)
€8.90
27.10.20
-
04.11.21
-24.99%
15.07.21

Risky Investment
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€6.50
27.10.20
-
29.10.20
-0.77%
29.10.20

Could be very worthwhile Investment >20% year
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€6.60
26.10.20
-
27.10.20
-1.52%
27.10.20

Could be very worthwhile Investment >20% year
Inovio Pharma

Start price
Target price
Perf. (%)
€8.90
26.10.20
-
27.10.20
0.00%
27.10.20

Risky Investment
Inovio Pharma

Start price
Target price
Perf. (%)
€8.95
26.10.20
-
26.10.20
-0.56%
26.10.20

Risky Investment
Inovio Pharma

Start price
Target price
Perf. (%)
€9.25
26.10.20
-
26.10.20
-3.24%
26.10.20

Risky Investment
buy
Borr Drilling Ltd

Start price
Target price
Perf. (%)
€0.71
24.10.20
€1.60
04.11.21
158.58%
05.11.21

Could be worthwhile Investment >10% per year
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€7.00
23.10.20
-
04.11.21
-37.53%
05.11.21

Risky Investment
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€2.10
23.10.20
€1.00
04.11.21
7.62%
04.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
buy
Mutares SE & Co. KgaA

Start price
Target price
Perf. (%)
€11.10
22.10.20
€12.00
04.11.21
112.61%
05.11.21

buy
ElringKlinger AG

Start price
Target price
Perf. (%)
€8.24
22.10.20
€18.00
04.11.21
47.57%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued